Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 November 2014 11:55
Experts have found that eribulin can extend the lives of women with aggressive forms of breast cancer by several months
Giving breast cancer patients a drug made from sea sponges can extend their lives by several months, according to a new study.
Researchers at the University of Leeds carried out two large-scale trials with more than 1,800 participants who had been diagnosed with metastatic breast cancer.
They found that the drug eribulin extended the women's survival by an average of more than two months.
Women who had advanced triple negative breast cancer - an aggressive form of the disease for which there are few treatment options - benefited the most from the drug, with their lifespans increasing by almost five months.
Those with HER2 negative breast cancer lived more than two months longer when given eribulin, it was found.
Martin Ledwick, head information nurse at Cancer Research UK, described the results as "encouraging" for those women whose cancers no longer respond to conventional treatments.
He said that eribulin is not a cure but an additional option to extend patients' lives - which could be "priceless" for the women and their families. It may give them the option to spend valuable time with their family and friends, or to embark on a holiday with the security provided by specialist travel insurance for cancer patients.
The drug was originally derived from Halichondria okadai, a sea sponge, although it is now produced in laboratories.
Chris Twelves, professor of clinical cancer pharmacology and oncology at the University of Leeds, said the findings show that eribulin can lead to a "substantial improvement" in women's survival rates.
He pointed out that, while the drug was previously only available for women who had undergone several rounds of chemotherapy, the EU has now also approved it for those who have not received as much treatment.
The findings of the study were presented at the National Cancer Research Institute's cancer conference in Liverpool.
26 September 2018
Loneliness amongst over-50s is set to soar over the coming decades, a leading charity has warned.
[more...]
25 September 2018
Two leading charities have called for better mental health support to be made available for patients living with breast cancer.
22 September 2018
The NHS should switch to electric vehicles across its organisations, health officials have advised.
21 September 2018
UK holidaymakers could be missing out on more than 60 direct flight routes thanks to Air Passenger Duty (APD), a report suggests.
20 September 2018
Living in areas with high levels of air pollution could be linked to an increased risk of dementia, new research suggests.
19 September 2018
Multiple sclerosis (MS) patients are shelling out tens of thousands of pounds for care - and many are unable to cover the costs, a leading charity has warned.
18 September 2018
As much as £6 of every £10 spent on domestic flights in the UK goes on Air Passenger Duty (APD), new research suggests.
15 September 2018
UK driving licences might become invalid in certain European countries if the UK crashes out of the EU with no deal, the Government has warned.
14 September 2018
Online crowdfunding for cancer treatments is indirectly advancing the rise of alternative "quack" therapies, experts have warned.
13 September 2018
A "wee-stick" like those used in pregnancy testing could be employed to prevent thousands of deaths from ovarian cancer.
11 September 2018
As many as 1.3 million passengers endured severe flight delays in the last year, a new study reveals.
08 September 2018
British Airways customers are cancelling their credit cards after the carrier was hit by a 15-day data breach that compromised the details of around 380,000 people.